Drug intelligence / Profile preview

Adsorbed Acellular DTP-IPV-Hib Combined Vaccine

Development stage
Unknown
Lead developer
Beijing Minhai Biological
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Adsorbed Acellular DTP-IPV-Hib Combined Vaccine is a pentavalent combination vaccine developed by Beijing Minhai Biotechnology, a wholly-owned subsidiary of Shenzhen Kangtai Biological Products. The vaccine is designed to induce active immunity against diphtheria, tetanus, pertussis, poliomyelitis, and invasive infections caused by Haemophilus influenzae type b (Hib) in infants and young children. By combining antigens for five major childhood diseases into a single formulation, it significantly reduces the number of required injections, thereby improving compliance and vaccination coverage. The vaccine is currently in Phase 3 clinical development in China.

Other names
DTaP-IPV-Hib vaccineHib-DTP-acellular poliovirus vaccine (Minhai Biological)五联苗五联疫苗吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌(结合)联合疫苗吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌联合疫苗吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌联合疫苗(五联苗)吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌联合疫苗(五联苗)

Beyond the preview

Go deeper on Adsorbed Acellular DTP-IPV-Hib Combined Vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adsorbed Acellular DTP-IPV-Hib Combined Vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call